-
Forward Look
The Time FactorOncologist and researcher Arjun Gupta discusses time toxicity and why it is important.
by Ashley P. Taylor
-
Forward Look
Imaging Predicts Early Response to Melanoma ImmunotherapyResearch shows a scan can reveal treatment responses just one week after people with melanoma start immunotherapy.
by Anna Azvolinsky
-
Forward Look
A Different Chemotherapy Approach for Ovarian CancerStudy suggests heated chemotherapy delivered to the abdominal cavity extends survival in advanced ovarian cancer.
by Kris Conner
-
Forward Look
Some Breast Cancer Patients Can Skip RadiationResearch suggests postmenopausal women over 50 with low-risk hormone receptor-positive breast cancer may forgo radiation after surgery.
by Darcy Lewis
-
From the Editor-in-Chief
Weight-loss Drugs and CancerObesity and increased cancer risk have been linked. Could new drugs promising to reduce weight also lower the risk of cancer?
by William G. Nelson, MD, PhD
-
To Understand Disparities, Look at the Broader Contexts
Researchers at the AACR Annual Meeting 2024 consider ways in which social and economic factors like location affect cancer risk and outcomes.
by Eric Fitzsimmons
-
Regular Aspirin Use May Help Fight Colorectal Cancer
Aspirin appears to activate an immune response against colorectal cancer in the early stages of the disease.
by Sandra Gordon
-
Progress Against Cancer
New research fuels progress in cancer survival, prevention and side effect management.
-
Vaccines Spark Activity in Pancreatic Cancer
Scientists thought pancreatic cancer wouldn’t respond to immunotherapy. Now research has found vaccines can trigger the immune system to fight the disease.
by Thomas Celona
-
Lifestyle Choices and Cancer
What people eat and drink and their level of physical activity can affect their risk of having cancer. New interventions aim to reduce risk factors.
by Kevin McLaughlin
Cancer Talk
Can Steroids Impair Immunotherapy for Cancer?
A new study suggests steroids could blunt the effects of some immunotherapies, but researchers say they remain necessary for some patients.
by Kyle Bagenstose
Treatment Combination Improves Survival in Platinum-resistant Ovarian CancerPreliminary results found that combining relacorilant with nab-paclitaxel improved outcomes for women with advanced ovarian cancer.
by Sandra Gordon
CAR T-cell Therapy Shows Response in Rare Brain CancerPotential new approach to treating diffuse intrinsic pontine glioma uses engineered immune cells infused directly to the brain.
by Taneia Surles
Technology’s Changing Role in Cancer CareExperts explain how artificial intelligence, nanotechnology and decentralized care are poised to improve research, detection and treatment.
by Thomas Celona